Catalyst Pharmaceuticals Inc (STU:CN2)
€ 20.71 0.15 (0.73%) Market Cap: 2.46 Bil Enterprise Value: 2.04 Bil PE Ratio: 18.19 PB Ratio: 3.87 GF Score: 88/100

Q3 2022 Catalyst Pharmaceuticals Inc Earnings Call Transcript

Nov 10, 2022 / 01:30PM GMT
Release Date Price: €14.79 (-0.81%)
Operator

Good day, ladies and gentlemen and welcome to the Catalyst Pharmaceutical Incorporated Third Quarter 2022 Financial Results conference call. (Operator Instructions)

At this time, it is my pleasure to turn the floor over to your host, Ali Grande, Chief Financial Officer. Ma'am, the floor is yours.

Alicia Grande
Catalyst Pharmaceuticals, Inc. - CAO, VP, Treasurer & CFO

Good morning, everyone, and thank you for joining our conference call to discuss Catalysts Third Quarter 2022 Financial Results and Corporate Highlights. Leading the call today is Patrick McEnany, Chairman and Chief Executive Officer. We are also joined by Dr. Steven Miller, our Chief Operating Officer and Chief Scientific Officer and Jeffrey Del Carmen, our Chief Commercial Officer. Further, for the Q&A session, we will also have Dr. Gary Ingenito, our Chief Medical and Regulatory Officer.

Before we begin, I would like to remind you that in the following comments and in the Q&A session, we will make statements about expected future results, which may be forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot